|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
|FPRX||Five Prime Therapeutics||37.99||0.05||0.13%||1.8B|
You can purchase shares of Five Prime Therapeutics (NASDAQ: FPRX) through any online brokerage.
The latest price target for Five Prime Therapeutics (NASDAQ: FPRX) was reported by Guggenheim on 2021-03-09. The analyst firm set a price target for 38.00 expecting FPRX to rise to within 12 months (a possible 0.03% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Five Prime Therapeutics (NASDAQ: FPRX) is $37.99 last updated Wed Apr 14 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Five Prime Therapeutics.
There is no upcoming split for Five Prime Therapeutics.